Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review

BACKGROUND: The optimal management of HBsAg-negative, anti-HBc-positive patients who receive immunosuppression remains unclarified. We systematically reviewed the available data on potential predictors of the risk of hepatitis B virus (HBV) reactivation in such patients. METHODS: A literature search...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholongitas, Evangelos, Haidich, Anna-Bettina, Apostolidou-Kiouti, Fani, Chalevas, Parthenis, Papatheodoridis, George V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033767/
https://www.ncbi.nlm.nih.gov/pubmed/29991894
http://dx.doi.org/10.20524/aog.2018.0266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033767/
https://www.ncbi.nlm.nih.gov/pubmed/29991894
http://dx.doi.org/10.20524/aog.2018.0266

Ejemplares similares